| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.005 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.095 | 0.005 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.15 | 0.005 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.007 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.007 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.088 | 0.007 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.092 | 0.008 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.008 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.082 | 0.008 |